1Riella C, Czarnecki PG, Steinman TI. Therapeutic advances in the treatment of polycystic kidney disease[J]. Nephron Clin Pract, 2014, 128(3-4): 297-302.
2Nol N, Rieu P. Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease[J]. Nephrol Ther, 2015, 11(4): 213-225.
3Li A, Tian X, Zhang X, et al. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice[J]. Am J Pathol, 2015, 185(10): 2843-2860.